Objective: To describe the successful treatment of PTSD associated nightmares in two patients with PTSD.
Case Summaries: The report of the successful use of clonidine to treat PTSD associated nightmares among two Veterans following combat exposure.
Discussion: Clonidine, a centrally acting alpha-agonist agent used to treat hypertension, stimulates alpha-adrenoreceptors in the brain stem. This action results in reduced sympathetic outflow from the central nervous system. We hypothesize that this central mechanism of action is why clonidine may be more effective in treating nightmares among patients with PTSD when compared with other agents.
Conclusion: Clonidine should be considered as an alternative in the treatment of nightmares among patients with PTSD.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2190/PM.44.2.g | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
An Expert Consensus Statement for Implementing Cognitive Behavioral Therapy for Nightmares in Adults.
Behav Sleep Med
January 2025
Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Objectives: Research supports cognitive behavioral therapies for nightmares (CBT-N) in adults. However, the nuances of implementation and unstandardized nomenclature for treatment components has created confusion in the field. To provide clarification, an expert consensus panel convened to review treatment manual components and to develop guidelines for the standardized implementation and terminology of CBT-N.
View Article and Find Full Text PDFCharacteristics of adverse events and clinical risks of Lecanemab based on FAERS data.
J Affect Disord
January 2025
Affiliated Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, Jiangsu 214151, China. Electronic address:
Objective: This study aims to analyze the distribution of adverse events (AEs) related to Lecanemab in real-world settings based on FAERS database data.
Methods: Using the FAERS database, AE data related to Lecanemab was collected from Q3 2023 to Q2 2024. Signal mining was conducted using frequency and Bayesian methods to identify positive signals associated with Lecanemab.
Effect of the Levels and Sources of Noise on the Sleep Quality of Conscious Patients in Emergency Intensive Care Unit.
Noise Health
January 2025
Department of EICU, Wenzhou Central Hospital; The Dingli Clinical College of Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
Purpose: This study aimed to assess the levels and sources of noise in the emergency intensive care unit (EICU) of an emergency department and investigate their effects on the sleep quality of conscious patients.
Methods: A study was conducted on patients admitted to the EICU from December 2020 to December 2023. They were categorised according to their sleep quality with the Pittsburgh Sleep Quality Index.
Dream Enactment Behaviour in Post-Traumatic Stress Disorder.
Eur J Psychotraumatol
December 2025
Department of Clinical Neurophysiology, Danish Center for Sleep Medicine, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Sleep disturbances are widely reported in Post-Traumatic Stress Disorder (PTSD). Although Dream Enactment Behaviour (DEB) has long been associated with PTSD, its high prevalence has only recently been recognized, sparking discussions about the classification of trauma-related sleep disorders. The impact of DEB on treatment outcomes in PTSD remains unexplored.
View Article and Find Full Text PDFThe clinical use of dream content in modern psychiatry.
Australas Psychiatry
January 2025
Inner South Mental Health Service, Southern Adelaide Local Health Network, Bedford Park, SA, Australia.
Objective: Though there is a rich psychoanalytic tradition investigating the content and phenomenology of dreams, the clinical use of this has fallen into widespread disuse. We have undertaken a narrative review of the clinical significance and utility of dream content.
Findings: Dream content may have useful clinical and prognostic value in a number of neurological and psychiatric conditions, including schizophrenia, borderline personality disorder, temporal lobe epilepsy, REM sleep behaviour disorder, dementia, the culture-bound syndrome of Latah, and substance use.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!